Archaeobotany in Australia and New Guinea : Practice, potential and prospects

Archaeobotany is the study of plant remains from archaeological contexts. Despite Australasian research being at the forefront of several methodological innovations over the last three decades, archaeobotany is now a relatively peripheral concern to most archaeological projects in Australia and New Guinea. In this paper, many practicing archaeobotanists working in these regions argue for a more central role for archaeobotany in standard archaeological practice. An overview of archaeobotanical techniques and applications is presented, the potential for archaeobotany to address key historical research questions is indicated, and initiatives designed to promote archaeobotany and improve current practices are outlined.

Communication and new media: From broadcast to narrowcast

Firmly grounded in a political economy approach, this new Canadian edition is an innovative introduction to media and communication that examines issues of ownership, access, and control as technologies combine to create new hybrid technologies that are changing the way we relate to each other and the world around us. Expertly adapted to meet the needs and interests of Canadian students, this text maintains a global perspective while integrating Canadian research, data, government policy and legislation, and examples throughout.

The politics of recognition and social justice : transforming subjectivities and new forms of resistance

Via a wide range of case studies, this book examines new forms of resistance to social injustices in contemporary Western societies. Resistance requires agency, and agency is grounded in notions of the subject and subjectivity. How do people make sense of their subjectivity as they are constructed and reconstructed within relations of power? What kinds of subjectivities are needed to struggle against forms of dominance and claim recognition? The participants in the case studies are challenging forms of dominance and subordination grounded in class, race, culture, nationality, sexuality, religion, age, disability and other forms of social division. It is a premise of this book that new and/or reconstructed forms of subjectivity are required to challenge social relations of subordination and domination. Thus, the transformation of subjectivity as well as the restructuring of oppressive power relations is necessary to achieve social justice. By examining the construction of subjectivity of particular groups through an intersectional lens, the book aims to contribute to theoretical accounts of how subjects are constituted and how they can develop a critical distance from their positioning.

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy

In Part 2 of this three part review of multiple sclerosis (MS) treatment with a particular focus on the Australian and New Zealand perspective, we review the newer therapies that have recently become available and emerging therapies that have now completed phase III clinical trial programs. We go on to compare the relative efficacies of these newer and emerging therapies alongside the existing therapies. The effectiveness of β-interferon in the treatment of different stages and the different disease courses of MS is critically reviewed with the conclusion that the absolute level of response in term of annualised relapse rates (where relapses occur) and MRI activity are similar, but are disappointing in terms of sustained disability progression for progressive forms of the disease. Finally we review the controversial area of combination therapy for MS. Whilst it remains the case that we have no cure or means of preventing MS, we do have a range of effective therapies that when used appropriately and early in the disease course can have a significant impact on short term and longer term outcomes.

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations

In this third and final part of our review of multiple sclerosis (MS) treatment we look at the practical day-to-day management issues that are likely to influence individual treatment decisions. Whilst efficacy is clearly of considerable importance, tolerability and the potential for adverse effects often play a significant role in informing individual patient decisions. Here we review the issues surrounding switching between therapies, and the evidence to assist guiding the choice of therapy to change to and when to change. We review the current level of evidence with regards to the management of women in their child-bearing years with regards to recommendations about treatment during pregnancy and whilst breast feeding. We provide a summary of recommended pre- and post-treatment monitoring for the available therapies and review the evidence with regards to the value of testing for antibodies which are known to be neutralising for some therapies. We review the occurrence of adverse events, both the more common and troublesome effects and those that are less common but have potentially much more serious outcomes. Ways of mitigating these risks and managing the more troublesome adverse effects are also reviewed. Finally, we make specific recommendations with regards to the treatment of MS. It is an exciting time in the world of MS neurology and the prospects for further advances in coming years are high.